Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans.
Matthias M MauschitzTimo VerzijdenAlexander K SchusterHisham ElbazNorbert PfeifferAnthony KhawajaRobert N LubenPaul J FosterFranziska G RauscherKerstin WirknerToralf KirstenJost Bruno JonasMukharram M BikbovRuth Esther HoggTunde PetoAudrey Cougnard-GrégoireGeir BertelsenMaja Gran ErkeFotis TopouzisDimitrios A GiannoulisCaroline BrandlIris M HeidCatherine P Creuzot-GarcherPierre Henri GabrielleHans-Werner HenseDaniel PauleikhoffPatricia BarretoRita CoimbraStefano PiermarocchiVincent DaienFrank G HolzCécile DelcourtRobert P Fingernull nullPublished in: The British journal of ophthalmology (2022)
Our study indicates a potential beneficial effect of LLD and antidiabetic drug use on prevalence of AMD across multiple European cohorts. Our findings support the importance of metabolic processes in the multifactorial aetiology of AMD.